(MedPage Today) — The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or without aura, Axsome Therapeutics announced.
Meloxicam is a COX-2 preferential non-steroidal anti-inflammatory…
Source link : https://www.medpagetoday.com/neurology/migraines/114036
Author :
Publish date : 2025-01-31 20:01:48
Copyright for syndicated content belongs to the linked Source.
